These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16822281)

  • 1. Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources.
    Trifirò G; Corrao S; Alacqua M; Moretti S; Tari M; Caputi AP; Arcoraci V;
    Br J Clin Pharmacol; 2006 Nov; 62(5):582-90. PubMed ID: 16822281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitor prescribing patterns and utilization: A retrospective chart review analysis.
    Algabbani AM; Alangari AS
    Saudi Pharm J; 2023 Dec; 31(12):101841. PubMed ID: 37961073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentially inappropriate proton-pump inhibitor prescription in the general population: a claims-based retrospective time trend analysis.
    Muheim L; Signorell A; Markun S; Chmiel C; Neuner-Jehle S; Blozik E; Ursprung P; Rosemann T; Senn O
    Therap Adv Gastroenterol; 2021; 14():1756284821998928. PubMed ID: 33948109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of potential drug interactions among psychiatric inpatients receiving antipsychotic therapy of a secondary care hospital, United Arab Emirates.
    Aburamadan HAR; Sridhar SB; Tadross TM
    J Adv Pharm Technol Res; 2021; 12(1):45-51. PubMed ID: 33532354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarity and consistency assessment of three major online drug-drug interaction resources.
    Kontsioti E; Maskell S; Bensalem A; Dutta B; Pirmohamed M
    Br J Clin Pharmacol; 2022 Sep; 88(9):4067-4079. PubMed ID: 35362214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing Consistency of Drug-Drug Interaction-Related Information Across Various Drug Information Resources.
    Shariff A; Belagodu Sridhar S; Abdullah Basha NF; Bin Taleth Alshemeil SSH; Ahmed Aljallaf Alzaabi NA
    Cureus; 2021 Mar; 13(3):e13766. PubMed ID: 33842142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteome-wide assessment of human interactome as a source of capturing domain-motif and domain-domain interactions.
    Idrees S; Paudel KR
    J Cell Commun Signal; 2024 Mar; 18(1):e12014. PubMed ID: 38545252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An introduction to network analysis for studies of medication use.
    Askar M; Cañadas RN; Svendsen K
    Res Social Adm Pharm; 2021 Dec; 17(12):2054-2061. PubMed ID: 34226152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review of Gastric Acid-Reducing Agent-Mediated Drug-Drug Interactions with Orally Administered Medications.
    Patel D; Bertz R; Ren S; Boulton DW; Någård M
    Clin Pharmacokinet; 2020 Apr; 59(4):447-462. PubMed ID: 31788764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cooperation project between hospital pharmacists and general practitioners about drug interactions in clinical practice.
    Vinciguerra V; Fantozzi R; Cena C; Fruttero R; Rolle C
    Eur J Hosp Pharm; 2018 Nov; 25(6):301-309. PubMed ID: 31157047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study.
    Lo Giudice I; Mocciaro E; Giardina C; Barbieri MA; Cicala G; Gioffrè-Florio M; Carpinteri G; Di Grande A; Spina E; Arcoraci V; Cutroneo PM
    BMC Pharmacol Toxicol; 2019 Apr; 20(1):21. PubMed ID: 31029178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of multimorbidity and polypharmacy in young and adult population: Systematic associations among chronic diseases and drugs using factor analysis.
    Menditto E; Gimeno Miguel A; Moreno Juste A; Poblador Plou B; Aza Pascual-Salcedo M; Orlando V; González Rubio F; Prados Torres A
    PLoS One; 2019; 14(2):e0210701. PubMed ID: 30726245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using electronic health records to characterize prescription patterns: focus on antidepressants in nonpsychiatric outpatient settings.
    Deferio JJ; Levin TT; Cukor J; Banerjee S; Abdulrahman R; Sheth A; Mehta N; Pathak J
    JAMIA Open; 2018 Oct; 1(2):233-245. PubMed ID: 30474077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?
    Trifirò G; Gini R; Barone-Adesi F; Beghi E; Cantarutti A; Capuano A; Carnovale C; Clavenna A; Dellagiovanna M; Ferrajolo C; Franchi M; Ingrasciotta Y; Kirchmayer U; Lapi F; Leone R; Leoni O; Lucenteforte E; Moretti U; Mugelli A; Naldi L; Poluzzi E; Rafaniello C; Rea F; Sultana J; Tettamanti M; Traversa G; Vannacci A; Mantovani L; Corrao G
    Drug Saf; 2019 Mar; 42(3):347-363. PubMed ID: 30269245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study.
    Giardina C; Cutroneo PM; Mocciaro E; Russo GT; Mandraffino G; Basile G; Rapisarda F; Ferrara R; Spina E; Arcoraci V
    Front Pharmacol; 2018; 9():350. PubMed ID: 29695966
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.
    Ferrara R; Ientile V; Arcoraci V; Ferrajolo C; Piccinni C; Fontana A; Benvenga S; Trifirò G
    Endocrine; 2017 Oct; 58(1):143-152. PubMed ID: 28155170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy.
    Trifirò G; Parrino F; Pizzimenti V; Giorgianni F; Sultana J; Muscianisi M; Troncone C; Tari DU; Arcoraci V; Santoro D; Russo G; Lacava V; Caputi AP
    Clin Drug Investig; 2016 Mar; 36(3):203-12. PubMed ID: 26692008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study.
    Ingrasciotta Y; Sultana J; Giorgianni F; Fontana A; Santangelo A; Tari DU; Santoro D; Arcoraci V; Perrotta M; Ibanez L; Trifirò G
    PLoS One; 2015; 10(4):e0122899. PubMed ID: 25880729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011.
    Italiano D; Capuano A; Alibrandi A; Ferrara R; Cannata A; Trifirò G; Sultana J; Ferrajolo C; Tari M; Tari DU; Perrotta M; Pagliaro C; Rafaniello C; Spina E; Arcoraci V
    Br J Clin Pharmacol; 2015 Jun; 79(6):1010-9. PubMed ID: 25556909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease requiring healthcare services: a new approach to evaluate epidemiology of renal disease.
    Trifirò G; Sultana J; Giorgianni F; Ingrasciotta Y; Buemi M; Muscianisi M; Tari DU; Perrotta M; Canale V; Arcoraci V; Santoro D
    Biomed Res Int; 2014; 2014():268362. PubMed ID: 25506054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.